PIVOTAL SCIENTIFIC IS ATTENDING AACR 2024

Nordic Immunological Labs Acquires MUbio

Exit Strategy 5

The Netherlands, 4 February 2013 Today, Nordic Immunological Laboratories BV acquired the assets of MUbio Holding BV. Nordic will continue to develop and manufacture high quality MUbio research antibody reagents in the same facilities and with the same key personnel as before, all according to strict ISO 9001 quality guidelines. CEO Ronald Rutten declared that … Read more